The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Expires: July 31, 2015
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ARCUTIS BIOTHERAPEUTICS INC COM 03969K108 649,126 46,300 SH SOLE 46,300 0 0
ARDELYX INC COM 039697107 1,314,768 335,400 SH SOLE 335,400 0 0
AVADEL PHARMACEUTICALS PLC COM SHS G29687103 873,495 98,700 SH SOLE 98,700 0 0
BENITEC BIOPHARMA INC COM NEW 08205P209 725,400 62,000 SH SOLE 62,000 0 0
BIOHAVEN LTD COM G1110E107 320,297 22,700 SH SOLE 22,700 0 0
BRIDGEBIO PHARMA INC COM 10806X102 1,122,680 26,000 SH SOLE 26,000 0 0
DISC MEDICINE INC COM 254604101 561,376 10,600 SH SOLE 10,600 0 0
FENNEC PHARMACEUTICALS INC COM 31447P100 1,624,310 195,700 SH SOLE 195,700 0 0
GERON CORP COM 374163103 705,000 500,000 SH SOLE 500,000 0 0
HUMACYTE INC COM 44486Q103 174,515 83,500 SH SOLE 83,500 0 0
INSMED INC COM PAR $.01 457669307 1,071,816 10,650 SH SOLE 10,650 0 0
JASPER THERAPEUTICS INC COM NEW 471871202 813,075 146,500 SH SOLE 146,500 0 0
KINIKSA PHARMACEUTICALS INTL ORD SHS CL A G52694109 1,270,053 45,900 SH SOLE 45,900 0 0
MERSANA THERAPEUTICS INC COM 59045L106 190,624 644,000 SH SOLE 644,000 0 0
MILESTONE PHARMACEUTICALS IN COM 59935V107 1,064,684 548,806 SH SOLE 548,806 0 0
MINERALYS THERAPEUTICS INC COM 603170101 1,068,870 79,000 SH SOLE 79,000 0 0
REGENXBIO INC COM 75901B107 474,128 57,750 SH SOLE 57,750 0 0
SERES THERAPEUTICS INC COM 81750R201 189,292 17,038 SH SOLE 17,038 0 0
SYNDAX PHARMACEUTICALS INC COM 87164F105 515,075 55,000 SH SOLE 55,000 0 0